1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,047 | 0,097 | 23.04. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.04. | IMPLANET reports Q1 revenue of €2.2M | 1 | Seeking Alpha | ||
| 09.04. | IMPLANET Reports its 2024 First-Quarter Revenue | 157 | Business Wire | +10% growth in the French market vs. 2023 Q1
Continued expansion of the SMTP surgical equipment distribution activity
Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168... ► Artikel lesen | |
| 06.03. | Implanet S.A. SPON ADS EACH REPR 0.05 ORD SHS reports FY results | 1 | Seeking Alpha | ||
| 06.03. | IMPLANET Reports Its 2023 Full-Year Results | 204 | Business Wire | Governance evolution in line with the agreement with Sanyou Medical
Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plan), a medical technology... ► Artikel lesen | |
| 02.02. | Implanet Announces the Success of Its Capital Increase | 388 | Business Wire | BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), (the "Company"), a medical technology... ► Artikel lesen | |
| 25.01. | Implanet Announces the Appointment of Max W. Painter as Vice-President and General Manager of its US Subsidiary | 394 | Business Wire | Over 25 years of experience in innovative medical technologies with world leaders in spine surgery Strong expertise in strategic and commercial management
Regulatory News:
IMPLANET... ► Artikel lesen | |
| 16.01. | Implanet reports Q4 revenue decline of 20% Y/Y | 1 | Seeking Alpha | ||
| 15.01. | IMPLANET Reports 2023 Annual Revenue of €7.4 Million | 369 | Business Wire | BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology company... ► Artikel lesen | |
| 12.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 12.01.2024 | 378 | Xetra Newsboard | Das Instrument 8040 SE0020354389 ZAPLOX AB EQUITY wird cum Kapitalmassnahme gehandelt am 12.01.2024 und ex Kapitalmassnahme am 15.01.2024 The instrument 8040 SE0020354389 ZAPLOX AB EQUITY is traded... ► Artikel lesen | |
| 11.01. | IMPLANET Announces Its 2024 Financial Calendar | 287 | Business Wire | Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the... ► Artikel lesen | |
| 04.01. | IMPLANET: Launch of an issue of new shares with preferential subscription rights | 590 | Business Wire | Fundraising of €6.38 million with preferential subscription rights, through the issue of New Shares with a ratio of 19 New Shares for 8 preferential subscription rights (which may be increased... ► Artikel lesen | |
| 12.12.23 | IMPLANET Announces the Launch of Its Training Program in Advance of Marketing its JAZZ Range in China | 313 | Business Wire | First Chinese surgeon participation in IMPLANET's JAZZ Academy
Registration of the JAZZ range with the Chinese health authorities is ongoing
Regulatory News:
IMPLANET (Euronext Growth:... ► Artikel lesen | |
| 11.12.23 | Validation by Sanyou Medical's Board of Directors of Its Commitment to Subscribe up to €5 Million to IMPLANET's Planned Capital Increase | 271 | Business Wire | The planned capital increase remains subject to the approval of the relevant Chinese government authorities, expected in January 2024
Drawdown by IMPLANET of the balance of the bond issue... ► Artikel lesen | |
| 16.11.23 | IMPLANET Receives the Approval of Its Shareholders for Its Planned Capital Increase | 346 | Business Wire | Adoption of resolutions at today's Extraordinary General Meeting concerning the capital increase to take place in January 2024
Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168... ► Artikel lesen | |
| 31.10.23 | IMPLANET plans €5.5m-€6.6m capital raise with shareholder rights issue | 2 | Investing.com | ||
| 31.10.23 | IMPLANET Specifies the Terms of Its Planned Capital Increase | 271 | Business Wire | Details regarding the terms for setting the price of the planned capital increase of between €5.5M and €6.4M to take place in January 2024, to be submitted to a vote at the Annuel General Meeting... ► Artikel lesen | |
| 17.10.23 | IMPLANET Announces Its 3Rd-quarter and 9-Month Revenue to September 30, 2023 | 310 | Business Wire | Proposed capital increase with preferential subscription rights to be carried out in January 2024 and put to a vote at an Extraordinary General Meeting to be held on November 16, 2023
Regulatory... ► Artikel lesen | |
| 11.10.23 | IMPLANET will hold an Extraordinary General Meeting on November 16, 2023, and announces the implementation of short-term financing of a maximum net amount of €1.0 million in the form of a bond issue | 400 | Business Wire | Extraordinary General Meeting called to approve the capital increase planned for January 2024
Drawdown of the first tranche of the bond issue representing 50% of the maximum total financing... ► Artikel lesen | |
| 28.09.23 | IMPLANET Signs an Agreement With Sanyou Medical for a Proposed Capital Increase With Preferential Subscription Rights | 384 | Business Wire | Proposed capital increase with preferential subscription rights, to be carried out in January 2024 to strengthen IMPLANET's equity capital and enable business development, subject to a vote at... ► Artikel lesen | |
| 28.09.23 | IMPLANET Publishes Its 2023 Half-Year Results | 429 | Business Wire | Revenue of €4.3 million in the first half of 2023, +4% compared with H1 2022
Continued dynamic R&D investment coupled with strict management of operating expenses, down 4% over the period... ► Artikel lesen |
Seite:
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INVITAE | 0,110 | 0,00 % | Invitae Corporation: Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial Results | SAN FRANCISCO, March 6, 2024 /PRNewswire/ -- Invitae (OTC: NVTA), a leading medical genetics company, today announced estimated unaudited fourth quarter and full year 2023 revenue, gross profit... ► Artikel lesen | |
| FRESENIUS | 27,660 | +1,02 % | Andritz, Fresenius, Lufthansa, Südzucker, Volkswagen - 4investors Aktien Top-News | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 52,16 | +1,36 % | DAX & Co: Sartorius, Netflix, Siemens Healthineers, LVMH, Aixtron und Rheinmetall im Fokus | Der DAX hat am Mittwoch seine Gewinne bis zum Handelsende wieder vollständig abgegeben. Am Ende ging er mit einem Plus von 0,02 Prozent auf 17.770,02 Zähler über die Ziellinie. Am heutigen Donnerstag... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,900 | +2,36 % | Fresenius Medical Care: Was war das denn gestern? | Mit einem Kursanstieg um satte 6,44 Prozent wurde Fresenius Medical Care am Montag klarer Tagessieger im MDAX. Aber was war da los, was trieb die Aktie so stark? Vorab-Ergebnisse zum ersten Quartal... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 102,60 | +4,06 % | Carl Zeiss Meditec: Risiken bei der Prognose | Am 8. Mai wird Carl Zeiss Meditec Zahlen zum zweiten Quartal publizieren. Die Analysten der Deutschen Bank rechnen beim Umsatz mit einem organischen Rückgang um 1 Prozent. Das EBIT soll um 27 Prozent... ► Artikel lesen | |
| RXSIGHT | 54,92 | 0,00 % | RxSight, Inc. - 8-K, Current Report | ||
| NEWGENIVF GROUP | 2,230 | 0,00 % | NewGenIVF Limited: NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings | BANGKOK, Thailand, April 22, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals... ► Artikel lesen | |
| MOBILE-HEALTH NETWORK SOLUTIONS | 23,000 | 0,00 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 18,800 | +4,16 % | Where Privia Health Gr Stands With Analysts | ||
| GERRESHEIMER | 102,00 | +0,69 % | Gerresheimer: Aktie im Aufwind - das steckt dahinter | Das Analystenhaus Stifel hat am Mittwoch seine Einschätzung zur Gerresheimer-Aktie erneuert und spricht nun eine klare Kaufempfehlung aus. Die Aktie ist am Vormittag stark gefragt und gehört zu den... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 53,75 | +5,00 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
| ECKERT & ZIEGLER | 37,320 | +2,81 % | Eckert & Ziegler: Kurssprung nach Vorab-Zahlen … was ist das wert? | Am Montagnachmittag wartete der Strahlentechnik-Spezialist Eckert & Ziegler mit vorläufigen Ergebnissen zum 1. Quartal auf. Die Aktie machte einen Satz nach oben ... wie lässt sich das charttechnisch... ► Artikel lesen | |
| PROGYNY | 32,370 | 0,00 % | Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care | ||
| ATRICURE | 23,150 | +1,94 % | AtriCure upgraded at Oppenheimer on valuation | ||
| LIFESTANCE HEALTH GROUP | 6,110 | 0,00 % | LifeStance Health Group, Inc.: LifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024 |
IMPLANET SA gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,061 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
